1.
1
Barnes PJ
, Chung KF
, Page CP
.
Inflammatory mediators of asthma: an update
.
Pharmacol Rev
. 1998;50:515–596
.
MEDLINE
2.
2
Thomas PS
.
Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma
.
Immunol Cell Biol
. 2001;79:132–140
.
MEDLINE |
CrossRef
3.
3
Kips JC
.
Cytokines in asthma
.
Eur Respir J Suppl
. 2001;34:24s–33s
.
MEDLINE
4.
4
Bochner BS
, Hudson SA
, Xiao HQ
, Liu MC
.
Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions
.
J Allergy Clin Immunol
. 2003;112:930–934
.
Abstract | Full Text |
Full-Text PDF (112 KB)
|
CrossRef
5.
5
Liu L
, Jarjour NN
, Busse WW
, Kelly EA
.
Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma
.
Am J Respir Crit Care Med
. 2004;169:1118–1124
.
CrossRef
6.
6
Hung CH
, Li CY
, Lai YS
, Hsu PC
, Hua YM
, Yang KD
.
Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma
.
Pediatr Allergy Immunol
. 2005;16:306–309
.
MEDLINE
7.
7
Leung TF
, Wong CK
, Lam CWK
, et al.
Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children
.
Eur Respir J
. 2003;21:616–620
.
MEDLINE |
CrossRef
8.
8
Imai T
, Baba M
, Nishimura M
, Kakizaki M
, Takagi S
, Yoshie O
.
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
.
J Biol Chem
. 1997;272:15036–15042
.
MEDLINE |
CrossRef
9.
9
Liu AH
, Zeiger R
, Sorkness C
, et al.
Development and cross-sectional validation of the Childhood Asthma Control Test
.
J Allergy Clin Immunol
. 2007;119:817–825
.
Abstract | Full Text |
Full-Text PDF (372 KB)
|
CrossRef
10.
10
Schatz M
, Sorkness CA
, Li JT
, et al.
Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists
.
J Allergy Clin Immunol
. 2006;117:549–556
.
Abstract | Full Text |
Full-Text PDF (181 KB)
|
CrossRef
11.
11
Global Initiative for Asthma. Global strategy for asthma management and prevention. In: National Institutes of Health. National Heart, Lung, and Blood Institute, 2008. Available at: http://www.ginasthma.com/ [Date accessed: December 20, 2008]
12.
12
Juniper EF
, Kline PA
, Vanzieleghem MA
, Ramsdale EH
, O'Byrne PM
, Hargreave FE
.
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
.
Am Rev Respir Dis
. 1990;142:832–836
.
MEDLINE
13.
13
National Institutes of Health
.
Expert panel report 3: guidelines for the diagnosis and management of asthma
.
Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
.
14.
14
Khor YH
, Feltis BN
, Reid DW
, et al.
Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction
.
Clin Exp Allergy
. 2007;37:1189–1198
.
CrossRef
15.
15
Nathan RA
, Sorkness CA
, Kosinski M
, et al.
Development of the asthma control test: a survey for assessing asthma control
.
J Allergy Clin Immunol
. 2004;113:59–65
.
Abstract | Full Text |
Full-Text PDF (90 KB)
|
CrossRef
16.
16
Burke C
, Power CK
, Norris A
, Condez A
, Schmekel B
, Poulter LW
.
Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma
.
Eur Respir J
. 1992;5:73–79
.
MEDLINE
17.
17
Burke CM
, Sreenan S
, Power CK
, Pathmakanthan S
, Poulter LW
.
Mechanism of action of inhaled corticosteroids in bronchial asthma: a controlled study
.
Eur Respir J
. 1994;7:421S;
.
18.
18
Barnes PJ
.
Molecular mechanisms of glucocorticoid action in asthma
.
Pulm Pharmacol Ther
. 1997;10:3–19
.
MEDLINE |
CrossRef
19.
19
Rizzo MC
, Sole D
.
Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy
.
J Pediatr (Rio J)
. 2006;82:S198–S205
.
MEDLINE
20.
20
Panina-Bordignon P
, Papi A
, Mariani M
, et al.
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
.
J Clin Invest
. 2001;107:1357–1364
.
MEDLINE |
CrossRef
21.
21
Lai ST
, Hung CH
, Hua YM
, Hsu SH
, Jong YJ
, Suen JL
.
T-helper 1-related chemokines in the exacerbation of childhood asthma
.
Pediatr Int
. 2008;50:99–102
.
CrossRef
22.
22
Kips JC
, Tavernier JH
, Joos GF
, Peleman RA
, Pauwels RA
.
The potential role of tumour necrosis factor alpha in asthma
.
Clin Exp Allergy
. 1993;23:247–250
.
MEDLINE |
CrossRef
23.
23
Kharitonov SA
, Barnes PJ
.
Exhaled biomarkers
.
Chest
. 2006;130:1541–1546
.
MEDLINE |
CrossRef
24.
24
Pijnenburg MW
, De Jongste JC
.
Exhaled nitric oxide in childhood asthma: a review
.
Clin Exp Allergy
. 2008;38:246–259
.
CrossRef
25.
25
Adams N
, Lasserson TJ
, Cates CJ
, Jones PW
.
Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
.
Cochrane Database Syst Rev
. 2007;
.
26.
26
Yang JZ
, Young AL
, Chiang PC
, Thurston A
, Pretzer DK
.
Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies
.
J Pharm Sci
. 2008;97:4869–4878
.
CrossRef